Literature DB >> 11369734

Comparison of surrogate with self-respondents regarding medical history and prior medication use.

L Lipworth1, J P Fryzek, C M Fored, W J Blot, J K McLaughlin.   

Abstract

BACKGROUND: The self-report of medical history and medication use is a common feature of epidemiological research.
METHODS: In a unique re-interview study, we evaluated the concordance of medical conditions and past medication use reported in two similar interviews 5 years apart.
RESULTS: In 196 re-interviews with the subjects themselves, and in 107 with next-of-kin of subjects who died after the first interview, agreement was good or excellent (kappa > or =0.40) for 90% (9/10) of the conditions asked about in the personal medical history for both next-of-kin and self-respondents. Agreement was excellent (kappa >0.75) for two conditions, high blood pressure and hysterectomy, among self-respondents. Self- and surrogate respondents also showed similar reproducibility for prescription medications, but next-of-kin respondents tended to have poor agreement (kappa <0.40) for over-the-counter (OTC) medications such as antacids, antihistamines, and analgesics. Next-of-kin also less reliably reported a family history of cancer. When analyses were stratified by type of surrogate respondent, concordance between the two interviews was generally higher for spouses than for other surrogate respondents.
CONCLUSIONS: This research demonstrates that personal medical history and prescription medication use may be as reliably reported by next-of-kin as self-respondents, but suggests that additional information may be needed to validate measures of OTC medication use and family history of cancer for next-of-kin respondents, possibly through the review of hospital records.

Entities:  

Mesh:

Year:  2001        PMID: 11369734     DOI: 10.1093/ije/30.2.303

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  3 in total

1.  Consistency of self-reported first-degree family history of cancer in a population-based study.

Authors:  Fernanda Lenara Roth; Suzi Alves Camey; Maira Caleffi; Lavínia Schuler-Faccini; Edenir Inêz Palmero; Carla Bochi; Susana Mayer Moreira; Luciane Kalakun; Roberto Giugliani; Patrícia Ashton-Prolla
Journal:  Fam Cancer       Date:  2009-01-20       Impact factor: 2.375

2.  Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk.

Authors:  P A Newcomb; A Trentham-Dietz; J M Hampton
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

3.  Reliability of Family Proxy Data for Studies of Malignant Mesothelioma: Results from the ATSDR Pilot Surveillance.

Authors:  Natalia Melnikova; Jennifer Wu; Wendy Kaye; Maureen Orr
Journal:  ISRN Oncol       Date:  2013-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.